These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29910690)

  • 1. A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells.
    Chen Z; Liu J; Chu D; Shan Y; Ma G; Zhang H; Zhang XD; Wang P; Chen Q; Deng C; Chen W; Dimitrov DS; Zhao Q
    Int J Biol Sci; 2018; 14(7):799-806. PubMed ID: 29910690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth.
    Gao J; Chesebrough JW; Cartlidge SA; Ricketts SA; Incognito L; Veldman-Jones M; Blakey DC; Tabrizi M; Jallal B; Trail PA; Coats S; Bosslet K; Chang YS
    Cancer Res; 2011 Feb; 71(3):1029-40. PubMed ID: 21245093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.
    De Vincenzo A; Belli S; Franco P; Telesca M; Iaccarino I; Botti G; Carriero MV; Ranson M; Stoppelli MP
    Int J Cancer; 2019 Nov; 145(10):2827-2839. PubMed ID: 31381136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.
    Yee D; Rosen N; Favoni RE; Cullen KJ
    Cancer Treat Res; 1991; 53():93-106. PubMed ID: 1672092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses.
    Qi L; Toyoda H; Shankar V; Sakurai N; Amano K; Kihira K; Iwasa T; Deguchi T; Hori H; Azuma E; Gabazza EC; Komada Y
    Cancer Sci; 2013 Sep; 104(9):1162-71. PubMed ID: 23710710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of insulin and IGF signaling in breast cancer: Implications for therapy.
    Lero MW; Shaw LM
    Mol Cell Endocrinol; 2021 May; 527():111213. PubMed ID: 33607269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Oxygen Tension Modulates the Insulin-Like Growth Factor-1 or -2 Signaling via Both Insulin-Like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem Cells.
    Youssef A; Han VK
    Endocrinology; 2016 Mar; 157(3):1163-74. PubMed ID: 26760116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.
    Belfiore A; Malaguarnera R; Nicolosi ML; Lappano R; Ragusa M; Morrione A; Vella V
    Cell Adh Migr; 2018; 12(4):305-314. PubMed ID: 29486622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells.
    Sarfstein R; Pasmanik-Chor M; Yeheskel A; Edry L; Shomron N; Warman N; Wertheimer E; Maor S; Shochat L; Werner H
    J Biol Chem; 2012 Jan; 287(4):2766-76. PubMed ID: 22128190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation.
    Hermanto U; Zong CS; Wang LH
    Cell Growth Differ; 2000 Dec; 11(12):655-64. PubMed ID: 11149601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation.
    Huang CT; Chang MC; Chen YL; Chen TC; Chen CA; Cheng WF
    Cancer Lett; 2015 Apr; 359(1):117-26. PubMed ID: 25592043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo.
    Dransfield DT; Cohen EH; Chang Q; Sparrow LG; Bentley JD; Dolezal O; Xiao X; Peat TS; Newman J; Pilling PA; Phan T; Priebe I; Brierley GV; Kastrapeli N; Kopacz K; Martik D; Wassaf D; Rank D; Conley G; Huang Y; Adams TE; Cosgrove L
    Mol Cancer Ther; 2010 Jun; 9(6):1809-19. PubMed ID: 20515953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
    Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
    Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factors and cancer.
    Yu H; Berkel H
    J La State Med Soc; 1999 Apr; 151(4):218-23. PubMed ID: 10234899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.